Institution statistics

FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE - Spain 

Ranking results:

Past rankings:
2015
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:700-800
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:200-300
2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 40
As coordinator: 4
As participant: 24
Sole participant: 12
Coordinator / Participant Ratio: 0.17*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 170.122 0 170.122 1
2018 644.486 0 644.486 4
2017 3.831.958 0 743.619 1
2016 158.122 1.999.960 2.158.082 1 1
2015 4.045.426 7.411.340 1.175.197 2 2
2014 352.176 0 352.176 1
2013 0 13.900.091 1.557.949 3
2012 3.512.185 18.340.793 1.835.438 3 4
2011 3.119.666 59.716.366 5.469.638 2 7
2010 241.761 30.059.334 1.018.973 1 6
2009 0 2.574.827 234.075 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE9
KAROLINSKA INSTITUTE6
UNIVERSITY COLLEGE LONDON6
DIAGENODE5
MEDIZINISCHE UNIVERSITAET WIEN5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM4
INSTITUT CATALA DE LA SALUT4
WEIZMANN INSTITUTE OF SCIENCE4
ACADEMISCH ZIEKENHUIS GRONINGEN3
CONSIGLIO NAZIONALE DELLE RICERCHE3
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT CATALA D'ONCOLOGIA3
KATHOLIEKE UNIVERSITEIT LEUVEN3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
STICHTING KATHOLIEKE UNIVERSITEIT3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE UNIVERSITY OF EDINBURGH3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITAET DES SAARLANDES3
UNIVERSITY OF HELSINKI3
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING2
CELLZOME2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
GOETEBORGS UNIVERSITET2
ISTITUTO EUROPEO DI ONCOLOGIA2
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI2
KING'S COLLEGE LONDON2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
LUNDS UNIVERSITET2
MOSAIQUES DIAGNOSTICS2
STENO DIABETES CENTER2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
THE BABRAHAM INSTITUTE2
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA2
THE UNIVERSITY OF LIVERPOOL2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITE DE GENEVE2
UNIVERSITE PARIS DESCARTES2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF NEWCASTLE UPON TYNE2
AARHUS UNIVERSITETSHOSPITAL SKEJBY1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENDIA NV1
AGILENT TECHNOLOGIES OESTERREICH1
ALMAC DIAGNOSTICS LIMITED1
AMC MEDICAL RESEARCH BV1
AMGEN1
APPLIED RESEARCH USING OMIC SCIENCES SL1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ARTTIC IN BRUSSELS SPRL1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION EUROPEENNE CONTRE LES LEUCODYSTROPHIES1
AVANTEA1
AVANTICELL SCIENCE1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1
AZIENDA OSPEDALIERA DI PADOVA1
AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA1
AZIENDA OSPEDALIERA SAN GIOVANNI BATTISTA DI TORINO1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BATAVIA BIOSERVICES BV1
BIOCOMUNICAT1
BIOCRATES LIFE SCIENCES1
BIOGAZELLE1
BIOLUTION1
BIOMAX INFORMATICS1
BOEHRINGER INGELHEIM RCV GMBH & CO KG1
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST1
CANCEROPOLE PACA1
CELERA CORPORATION1
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1
CESAR CENTRAL EUROPEAN SOCIETY FOR ANTICANCER DRUG RESEARCH EWIV1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CLC BIO1
CRUCELL HOLLAND B V1
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DIGNA BIOTECH SL1
DUBLIN CITY UNIVERSITY1
EMERGENTEC BIODEVELOPMENT1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EURAM LIMITED1
EUROPEAN CERVICAL CANCER ASOCIATION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN RESEARCH AND PROJECT OFFICE1
EVOTEC SAS1
FONDATION DU CENTRE PLURIDISCIPLINAIRE D'ONCOLOGIE1
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA1
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA1
FORSCHUNGSVERBUND BERLIN EV1
FRANCE EUROPE INNOVATION1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
Constancy:

Total number of partners:322

Partner loyalty:
Frequent Partner: (> 2 projects): 87
Rare Partner: 235

Frequent / Rare Partner Ratio: 0.37

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES21
RTD HORIZONTAL TOPICS9
SOCIAL AND ECONOMIC CONCERNS6

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-02Identification of a novel function of lysosomes in mitosis for cancer therapy M-Lysosomescoordinator170.1221
2018-09-05DNA MEthylation for HPV-related disease among women living with HIV MEsHHcoordinator158.1221
2018-09-03Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective. MECoCaMcoordinator158.1221
2018-09-01Activation of PI3K signalling in the pathogenesis of Vascular Anomalies PI3K-VAscoordinator158.1221
2018-04-01Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX) PORTALcoordinator170.1221
2017-09-01Targeting the metabolism-immune system connections in Cancer META-CANcoordinator3.831.95820
2016-10-01Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity PLEIO-RANKparticipant1.999.9601
2016-03-01Identification and Characterization of Cis-Regulatory ModuleDysfunction in Rett Syndrome with ROQ-WACh ROQ-WAChcoordinator158.1221
2015-11-01Deciphering PI3K biology in health and disease Phdcoordinator3.896.14813
2015-10-01Endoplasmic Reticulum Stress in Health and Disease TRAIN-ERSparticipant3.628.75712
2015-02-01Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary EPICUPcoordinator149.2781
2015-01-01Chromatin Dynamics in Development and Disease Chromatin3Dparticipant3.782.58312
2014-04-23Crosstalk between microRNAs and epigenetics in melanocyte differentiation: A new approach to unravel the complexity of melanoma progression and metastasis EPIMIRMELcoordinator352.1761
2013-09-01Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves TRANSLINKparticipant5.996.97113
2013-03-01Epigenetic Training Network - Innovative techniques and models to understand epigenetic regulation in the pathogenesis of common diseases EPITRAINparticipant3.816.5486
2013-01-01Vascular Endothelial interactionS and SpEciaLization VESSELparticipant4.086.5729
2012-10-01STRATEGY TO INHIBIT TGF-Beta IN LIVER DISEASE IT-LIVERcoordinator3.312.18511
2012-10-01"User-driven Development of Statistical Methods for Experimental Planning, Data Gathering, and Integrative Analysis of Next Generation Sequencing, Proteomics and Metabolomics data" STATEGRAparticipant5.998.57511
2012-04-01ADenoViruses as novel clinical treatments ADVanceparticipant3.861.45013
2012-03-01The Role of the RPL11/p53 Checkpoint in the Development and Treatment of DBA DBA-Checkpointscoordinator100.0001
2012-01-01Mechanisms of prevention of type 2 diabetes by lifestyle intervention in subjects with pre-diabetes or at high-risk for progression DEXLIFEparticipant5.486.63110
2012-01-01Modulation of AMPA receptor properties by auxiliary subunits MOAMAUXcoordinator100.0001
2012-01-01Pathways common to brain development and ageing: defining strategies for preventive therapy and diagnostics DEVELAGEparticipant2.994.1379
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-09-01Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe HPV-AHEADparticipant2.999.94611
2011-05-01Use of adoptive T cell transfer in combination with oncolytic adenoviruses for cancer treatment Cancer therapiesparticipant223.6702
2011-04-01Epigenetic Disruption of Non-Coding RNAs in Human Cancer EPINORCparticipant2.497.2401
2011-03-01European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity EuroTARGETparticipant5.999.55015
2011-02-01Breaking Tolerance - Combination of Virotherapy and Immunotherapy for Cancer Treatment Viral&Immune Therapycoordinator153.9171
2011-01-01Modelling and predicting sensitivity to targeted therapies in colorectal cancers COLTHERESparticipant5.999.30011
2011-01-01Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis CURELUNGcoordinator2.965.74911
2011-01-01Systems Biology of Colorectal Cancer SYSCOLparticipant11.999.99611
2010-12-01Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation MABSOTparticipant5.929.06410
2010-11-01Genomic predictors and oncogenic drivers in hepatocellular carcinoma HEPTROMICparticipant2.999.47810
2010-08-02Assembly of a prostate cancer genome-wide molecular interactome for the identification of the key regulatory genes of malignant transformation and new targets for therapeutic intervention PC interactomecoordinator241.7611
2010-07-01Immunomodulatory Effects of Exercise in Type 1 Diabetes IMMEEDIAparticipant399.6005
2010-05-01health-economic modelling of PREvention strategies for Hpv-related Diseases in European CounTries PREHDICTparticipant2.963.53213
2010-03-01Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials LeukoTreatparticipant5.978.12625
2010-01-01Systems biology towards novel chronic kidney disease diagnosis and treatment SysKIDparticipant11.789.53429
2009-11-01Chromatin diseases: from basic mechanisms to therapy DISCHROMparticipant2.574.82711
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum